ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

Rosen Law Firm is reminding investors in Gossamer Bio, ImmunityBio, and Immutep Ltd. about upcoming deadlines to join securities class action lawsuits. The lawsuits allege that defendants made false and misleading statements to investors, with Gossamer Bio specifically accused of concealing material adverse facts concerning its Phase 3 PROSERA study design. Investors who purchased securities during specified class periods may be eligible for compensation.